GSK-MY-1048/BRL-029060/1/CPMS-223 (PAR 223)

A Double-Blind, Multicentered, Flexible-Dose Study of Paroxetine, Alprazolam and Placebo in the Treatment of Panic Disorder
MY-1048/BRL-029060/1/CPMS-223 (PAR 223)
Panic Disorder
Phase 3
The data from this study is provided in combined datasets containing data from other paroxetine studies. A raw dataset, an annotated case report form, a reporting and analysis plan, a clinical study report, and a protocol are not available for this study. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
December 2014